National Holdings (NHLD) 3.18 $NHLD Nano Dimens
Post# of 273249
Posted On: 09/27/2016 3:27:50 PM
National Holdings (NHLD) 3.18 $NHLD
Nano Dimension Ltd. Raises $12M in Public Offering of American Depositary Shares
PR Newswire - Tue Sep 27, 1:30AM CDT
Nano Dimension Ltd., a leader in the field of 3D Printed Electronics (NASDAQ, TASE: NNDM), today announced the pricing of its public offering of 1,850,000 American Depository Shares (ADSs) at a price of $6.50 per ADS. In addition, Nano Dimension has granted the underwriters a 45-day over-allotment option to purchase up to 277,500 additional ADSs at the public offering price. All of the ADSs are being offered by the Company.
NNDM: 7.50 (-0.43), NHLD: 3.18 (-0.10)
Capricor Therapeutics Announces Closing of Public Offerings Raising Approximately $10.0 Million in Net Proceeds
PR Newswire - Wed Sep 21, 10:00AM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR) today announced the closing of its previously announced underwritten registered public offering and concurrent registered direct offering. In the registered public offering, a total of 3,090,625 shares of the Company's common stock were sold at an offering price of $3.20 per share. The shares include 403,125 shares of common stock sold pursuant to the underwriters' over-allotment option, which option was exercised in full. In the registered direct offering, a total of 312,500 shares of the Company's common stock were sold by Capricor directly to Cedars-Sinai Medical Center at a price of $3.20 per share.
CAPR: 3.32 (+0.03), NHLD: 3.18 (-0.10)
Capricor Therapeutics Announces Pricing of Offerings of Common Stock
PR Newswire - Fri Sep 16, 8:00AM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR) today announced the pricing of its offerings of 3,000,000 shares of its common stock at an offering price of $3.20 per share, before underwriting discounts. 2,687,500 shares of Capricor's common stock will be purchased by the underwriters in an underwritten registered public offering and 312,500 shares will be purchased by Cedars-Sinai Medical Center, a stockholder of Capricor, from Capricor directly and not through the underwriters in a concurrent registered direct offering. Capricor has granted the underwriters a 30-day option to purchase up to an additional 403,125 shares of its common stock. The proceeds to Capricor from the offerings are expected to be approximately $8.7 million after deducting underwriting discounts and commissions and other estimated offering expenses but excluding any exercise of the underwriters' option. All shares of common stock to be sold in the offerings are being offered by Capricor. The offerings are expected to close on or about September 21, 2016, subject to customary closing conditions.
CAPR: 3.32 (+0.03), NHLD: 3.18 (-0.10)
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
PR Newswire - Thu Sep 15, 3:05PM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR) today announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Roth Capital Partners and National Securities Corporation, a wholly-owned subsidiary of National Holdings, Inc., are acting as joint book-running managers for the offering.
CAPR: 3.32 (+0.03), NHLD: 3.18 (-0.10)
Resonant Closes $11.5 Million Public Offering of Its Common Stock
BusinessWire - Wed Sep 14, 10:45AM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced the closing of an underwritten public offering for 2,715,000 shares of its common stock, which includes the exercise in full by the underwriters of their over-allotment option, at a per share price to the public of $4.25. The Company will receive gross proceeds of approximately $11.5 million from the offering.
RESN: 5.32 (-0.18), NHLD: 3.18 (-0.10)
Fortress Biotech Completes Tender Offer for Shares of National Holdings Corporation
GlobeNewswire - Mon Sep 12, 7:30AM CDT
Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress" or "FBIO"
and National Holdings Corporation (NASDAQ:NHLD) ("NHLD" today announced that an affiliate of Fortress, FBIO Acquisition, Inc., has completed its previously announced tender offer (the "Offer" to purchase all outstanding shares of NHLD for $3.25 per share, net to the seller in cash but subject to any required withholding of taxes.
FBIO: 2.96 (-0.02), NHLD: 3.18 (-0.10)
Resonant Prices Underwritten Public Offering of Common Stock
BusinessWire - Fri Sep 09, 7:30AM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced the pricing of an underwritten public offering of 2,360,870 shares of its common stock at a price to the public of $4.25 per share, for gross proceeds of approximately $10.0 million. The Company has also granted to the underwriters a 30-day option to purchase, at the same price per share as the underwriters paid for the initial shares, an additional 354,130 shares to cover over-allotments in connection with the offering, which if exercised in full would increase the gross proceeds to approximately $11.5 million.
RESN: 5.32 (-0.18), NHLD: 3.18 (-0.10)
Resonant Announces Proposed Public Offering of Common Stock
BusinessWire - Thu Sep 08, 3:05PM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced that it is offering to sell shares of its common stock in an underwritten public offering. The offering is expected to price on or about Friday, September 9, 2016.
RESN: 5.32 (-0.18), NHLD: 3.18 (-0.10)
National Holdings Corporation Schedules Fiscal 2016 Third Quarter Earnings Release and Conference Call
BusinessWire - Thu Aug 11, 3:00PM CDT
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company" announced today that it will report its fiscal 2016 third quarter financial results on Monday, August 15, 2016 after the close of the financial markets. Management will host a conference call to discuss the operating and financial results and take investor questions at 9:00 am ET on Tuesday, August 16, 2016.
NHLD: 3.18 (-0.10)
Atomera Announces Pricing of Initial Public Offering
PRWeb - Thu Aug 04, 4:02PM CDT
Atomera Incorporated (NASDAQ: ATMR), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the $350+ billion semiconductor industry, today announced the pricing of its initial public offering of 3,200,000 shares of common stock at a public offering price of $7.50 per share. The Company expects its shares to begin trading on the NASDAQ Capital Market on Friday, August 5, 2016 under the trading symbol "ATMR."
NHLD: 3.18 (-0.10), ATMR: 8.02 (-0.03)
Tonix Pharmaceuticals Completes $10 Million Public Offering of Common Stock
GlobeNewswire - Tue Jun 21, 11:00AM CDT
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), today announced the closing of its previously announced underwritten public offering of 5,000,000 shares of its common stock. The shares were sold at the public offering price of $2.00 per share, bringing the aggregate gross proceeds from the offering to $10 million, before deducting underwriting discounts and commissions and other offering expenses. The financing was led by healthcare focused institutional investors.
TNXP: 0.69 (-0.01), NHLD: 3.18 (-0.10)
Champions Oncology, Inc. Announces Closing of Public Offering of Common Stock
PR Newswire - Wed Jun 15, 11:00AM CDT
Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the closing of its previously announced underwritten public offering of 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, the Company announced today the partial exercise of the over-allotment option granted to the underwriter to purchase an additional 258,749 shares of its common stock at the public offering price. All of the shares have been offered by the Company. The shares of Champions Oncology, Inc. are currently trading on NASDAQ under the symbol "CSBR".
CSBR: 1.70 (+0.02), NHLD: 3.18 (-0.10)
Champions Oncology, Inc. Announces Pricing of Public Offering of Common Stock
PR Newswire - Thu Jun 09, 6:30PM CDT
Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the pricing of its previously announced underwritten public offering. The Company is offering 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, Champions Oncology, Inc. has granted the underwriter a 45-day over-allotment option to purchase up to 300,000 additional shares of common stock at the public offering price. All of the shares are being offered by the Company. The shares of Champions Oncology, Inc. are currently trading on NASDAQ under the symbol "CSBR".
CSBR: 1.70 (+0.02), NHLD: 3.18 (-0.10)
Interstate Batteries and Aqua Metals Form Strategic Partnership
GlobeNewswire - Thu May 19, 7:30AM CDT
Aqua Metals, Inc. (NASDAQ:AQMS) (Aqua Metals), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining(TM), today announced the signing of definitive agreements with Interstate Batteries. Interstate Batteries is the No. 1 replacement battery brand, the largest independent battery distribution system in North America and the country's leading battery recycler.
AQMS: 8.60 (-0.10), NHLD: 3.18 (-0.10)
Scott K. Stucky Appointed Executive Vice-President of Software & Data Services at SettlementOne
PR Newswire - Wed May 18, 7:17AM CDT
Sackett National Holdings, Inc. (SNH), a leading provider of lending data, energy, employment screening and automotive products and services, today announced that Scott K. Stucky has been appointed Executive Vice-President, Software & Data Solutions, for SNH financial subsidiary SettlementOne.
NHLD: 3.18 (-0.10)
National Holding Corporation Announces Fiscal Second Quarter 2016 Financial Results
BusinessWire - Mon May 16, 4:01PM CDT
National Holding Corporation (NASDAQ:NHLD) ("National" or the "Company", a leading full service independent brokerage, investment banking and asset management firm providing diverse services including tax preparation & accounting services, today announced its financial results for the fiscal second quarter 2016 ended March 31, 2016.
NHLD: 3.18 (-0.10)
National Holdings Corporation Schedules Fiscal 2016 Second Quarter Earnings Release and Conference Call
BusinessWire - Wed May 11, 7:00AM CDT
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company" announced today that it will report its fiscal 2016 second quarter financial results on Monday, May 16, 2016 after the close of the financial markets. Management will host a conference call to discuss the operating and financial results and take investor questions at 9:00am ET on Tuesday, May 17, 2016.
NHLD: 3.18 (-0.10)
Fortress Biotech Reports First Quarter 2016 Financial Results and Recent Corporate Highlights
GlobeNewswire - Tue May 10, 4:10PM CDT
Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress", a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced its financial results and recent corporate highlights for the quarter ended March 31, 2016.
FBIO: 2.96 (-0.02), NHLD: 3.18 (-0.10)
Fortress Biotech and National Holdings Announce Agreement
Marketwired - Thu Apr 28, 7:50AM CDT
National Holdings Corporation (NASDAQ: NHLD) ("National Holdings" or "NHLD", a full-service investment banking and asset management firm, and Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress" or "FBIO", a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, announce today that the two firms have entered into a definitive agreement (the "Agreement" pursuant to which Fortress will offer to purchase, through its wholly owned subsidiary, FBIO Acquisition, Inc., up to 100% of the shares of National Holdings at $3.25 per share in cash. The offer price represents a premium of ~44% over the closing price of NHLD common stock on April 27, 2016, the last trading day prior to today's announcement.
FBIO: 2.96 (-0.02), NHLD: 3.18 (-0.10)
Resonant Inc. Announces Closing of Private Placement Raising Approximately $6 million in Gross Proceeds
BusinessWire - Tue Apr 26, 6:30AM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced it has closed its previously announced private placement of units (the Offering) with various institutional and individual accredited investors and certain of the Company's officers and directors. Resonant raised gross proceeds of approximately $6 million in the Offering.
RESN: 5.32 (-0.18), NHLD: 3.18 (-0.10)
Nano Dimension Ltd. Raises $12M in Public Offering of American Depositary Shares
PR Newswire - Tue Sep 27, 1:30AM CDT
Nano Dimension Ltd., a leader in the field of 3D Printed Electronics (NASDAQ, TASE: NNDM), today announced the pricing of its public offering of 1,850,000 American Depository Shares (ADSs) at a price of $6.50 per ADS. In addition, Nano Dimension has granted the underwriters a 45-day over-allotment option to purchase up to 277,500 additional ADSs at the public offering price. All of the ADSs are being offered by the Company.
NNDM: 7.50 (-0.43), NHLD: 3.18 (-0.10)
Capricor Therapeutics Announces Closing of Public Offerings Raising Approximately $10.0 Million in Net Proceeds
PR Newswire - Wed Sep 21, 10:00AM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR) today announced the closing of its previously announced underwritten registered public offering and concurrent registered direct offering. In the registered public offering, a total of 3,090,625 shares of the Company's common stock were sold at an offering price of $3.20 per share. The shares include 403,125 shares of common stock sold pursuant to the underwriters' over-allotment option, which option was exercised in full. In the registered direct offering, a total of 312,500 shares of the Company's common stock were sold by Capricor directly to Cedars-Sinai Medical Center at a price of $3.20 per share.
CAPR: 3.32 (+0.03), NHLD: 3.18 (-0.10)
Capricor Therapeutics Announces Pricing of Offerings of Common Stock
PR Newswire - Fri Sep 16, 8:00AM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR) today announced the pricing of its offerings of 3,000,000 shares of its common stock at an offering price of $3.20 per share, before underwriting discounts. 2,687,500 shares of Capricor's common stock will be purchased by the underwriters in an underwritten registered public offering and 312,500 shares will be purchased by Cedars-Sinai Medical Center, a stockholder of Capricor, from Capricor directly and not through the underwriters in a concurrent registered direct offering. Capricor has granted the underwriters a 30-day option to purchase up to an additional 403,125 shares of its common stock. The proceeds to Capricor from the offerings are expected to be approximately $8.7 million after deducting underwriting discounts and commissions and other estimated offering expenses but excluding any exercise of the underwriters' option. All shares of common stock to be sold in the offerings are being offered by Capricor. The offerings are expected to close on or about September 21, 2016, subject to customary closing conditions.
CAPR: 3.32 (+0.03), NHLD: 3.18 (-0.10)
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
PR Newswire - Thu Sep 15, 3:05PM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR) today announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Roth Capital Partners and National Securities Corporation, a wholly-owned subsidiary of National Holdings, Inc., are acting as joint book-running managers for the offering.
CAPR: 3.32 (+0.03), NHLD: 3.18 (-0.10)
Resonant Closes $11.5 Million Public Offering of Its Common Stock
BusinessWire - Wed Sep 14, 10:45AM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced the closing of an underwritten public offering for 2,715,000 shares of its common stock, which includes the exercise in full by the underwriters of their over-allotment option, at a per share price to the public of $4.25. The Company will receive gross proceeds of approximately $11.5 million from the offering.
RESN: 5.32 (-0.18), NHLD: 3.18 (-0.10)
Fortress Biotech Completes Tender Offer for Shares of National Holdings Corporation
GlobeNewswire - Mon Sep 12, 7:30AM CDT
Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress" or "FBIO"
and National Holdings Corporation (NASDAQ:NHLD) ("NHLD" today announced that an affiliate of Fortress, FBIO Acquisition, Inc., has completed its previously announced tender offer (the "Offer" to purchase all outstanding shares of NHLD for $3.25 per share, net to the seller in cash but subject to any required withholding of taxes. FBIO: 2.96 (-0.02), NHLD: 3.18 (-0.10)
Resonant Prices Underwritten Public Offering of Common Stock
BusinessWire - Fri Sep 09, 7:30AM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced the pricing of an underwritten public offering of 2,360,870 shares of its common stock at a price to the public of $4.25 per share, for gross proceeds of approximately $10.0 million. The Company has also granted to the underwriters a 30-day option to purchase, at the same price per share as the underwriters paid for the initial shares, an additional 354,130 shares to cover over-allotments in connection with the offering, which if exercised in full would increase the gross proceeds to approximately $11.5 million.
RESN: 5.32 (-0.18), NHLD: 3.18 (-0.10)
Resonant Announces Proposed Public Offering of Common Stock
BusinessWire - Thu Sep 08, 3:05PM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced that it is offering to sell shares of its common stock in an underwritten public offering. The offering is expected to price on or about Friday, September 9, 2016.
RESN: 5.32 (-0.18), NHLD: 3.18 (-0.10)
National Holdings Corporation Schedules Fiscal 2016 Third Quarter Earnings Release and Conference Call
BusinessWire - Thu Aug 11, 3:00PM CDT
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"
announced today that it will report its fiscal 2016 third quarter financial results on Monday, August 15, 2016 after the close of the financial markets. Management will host a conference call to discuss the operating and financial results and take investor questions at 9:00 am ET on Tuesday, August 16, 2016. NHLD: 3.18 (-0.10)
Atomera Announces Pricing of Initial Public Offering
PRWeb - Thu Aug 04, 4:02PM CDT
Atomera Incorporated (NASDAQ: ATMR), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the $350+ billion semiconductor industry, today announced the pricing of its initial public offering of 3,200,000 shares of common stock at a public offering price of $7.50 per share. The Company expects its shares to begin trading on the NASDAQ Capital Market on Friday, August 5, 2016 under the trading symbol "ATMR."
NHLD: 3.18 (-0.10), ATMR: 8.02 (-0.03)
Tonix Pharmaceuticals Completes $10 Million Public Offering of Common Stock
GlobeNewswire - Tue Jun 21, 11:00AM CDT
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), today announced the closing of its previously announced underwritten public offering of 5,000,000 shares of its common stock. The shares were sold at the public offering price of $2.00 per share, bringing the aggregate gross proceeds from the offering to $10 million, before deducting underwriting discounts and commissions and other offering expenses. The financing was led by healthcare focused institutional investors.
TNXP: 0.69 (-0.01), NHLD: 3.18 (-0.10)
Champions Oncology, Inc. Announces Closing of Public Offering of Common Stock
PR Newswire - Wed Jun 15, 11:00AM CDT
Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the closing of its previously announced underwritten public offering of 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, the Company announced today the partial exercise of the over-allotment option granted to the underwriter to purchase an additional 258,749 shares of its common stock at the public offering price. All of the shares have been offered by the Company. The shares of Champions Oncology, Inc. are currently trading on NASDAQ under the symbol "CSBR".
CSBR: 1.70 (+0.02), NHLD: 3.18 (-0.10)
Champions Oncology, Inc. Announces Pricing of Public Offering of Common Stock
PR Newswire - Thu Jun 09, 6:30PM CDT
Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the pricing of its previously announced underwritten public offering. The Company is offering 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, Champions Oncology, Inc. has granted the underwriter a 45-day over-allotment option to purchase up to 300,000 additional shares of common stock at the public offering price. All of the shares are being offered by the Company. The shares of Champions Oncology, Inc. are currently trading on NASDAQ under the symbol "CSBR".
CSBR: 1.70 (+0.02), NHLD: 3.18 (-0.10)
Interstate Batteries and Aqua Metals Form Strategic Partnership
GlobeNewswire - Thu May 19, 7:30AM CDT
Aqua Metals, Inc. (NASDAQ:AQMS) (Aqua Metals), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining(TM), today announced the signing of definitive agreements with Interstate Batteries. Interstate Batteries is the No. 1 replacement battery brand, the largest independent battery distribution system in North America and the country's leading battery recycler.
AQMS: 8.60 (-0.10), NHLD: 3.18 (-0.10)
Scott K. Stucky Appointed Executive Vice-President of Software & Data Services at SettlementOne
PR Newswire - Wed May 18, 7:17AM CDT
Sackett National Holdings, Inc. (SNH), a leading provider of lending data, energy, employment screening and automotive products and services, today announced that Scott K. Stucky has been appointed Executive Vice-President, Software & Data Solutions, for SNH financial subsidiary SettlementOne.
NHLD: 3.18 (-0.10)
National Holding Corporation Announces Fiscal Second Quarter 2016 Financial Results
BusinessWire - Mon May 16, 4:01PM CDT
National Holding Corporation (NASDAQ:NHLD) ("National" or the "Company"
, a leading full service independent brokerage, investment banking and asset management firm providing diverse services including tax preparation & accounting services, today announced its financial results for the fiscal second quarter 2016 ended March 31, 2016. NHLD: 3.18 (-0.10)
National Holdings Corporation Schedules Fiscal 2016 Second Quarter Earnings Release and Conference Call
BusinessWire - Wed May 11, 7:00AM CDT
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"
announced today that it will report its fiscal 2016 second quarter financial results on Monday, May 16, 2016 after the close of the financial markets. Management will host a conference call to discuss the operating and financial results and take investor questions at 9:00am ET on Tuesday, May 17, 2016. NHLD: 3.18 (-0.10)
Fortress Biotech Reports First Quarter 2016 Financial Results and Recent Corporate Highlights
GlobeNewswire - Tue May 10, 4:10PM CDT
Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress"
, a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced its financial results and recent corporate highlights for the quarter ended March 31, 2016. FBIO: 2.96 (-0.02), NHLD: 3.18 (-0.10)
Fortress Biotech and National Holdings Announce Agreement
Marketwired - Thu Apr 28, 7:50AM CDT
National Holdings Corporation (NASDAQ: NHLD) ("National Holdings" or "NHLD"
, a full-service investment banking and asset management firm, and Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress" or "FBIO", a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, announce today that the two firms have entered into a definitive agreement (the "Agreement" pursuant to which Fortress will offer to purchase, through its wholly owned subsidiary, FBIO Acquisition, Inc., up to 100% of the shares of National Holdings at $3.25 per share in cash. The offer price represents a premium of ~44% over the closing price of NHLD common stock on April 27, 2016, the last trading day prior to today's announcement. FBIO: 2.96 (-0.02), NHLD: 3.18 (-0.10)
Resonant Inc. Announces Closing of Private Placement Raising Approximately $6 million in Gross Proceeds
BusinessWire - Tue Apr 26, 6:30AM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced it has closed its previously announced private placement of units (the Offering) with various institutional and individual accredited investors and certain of the Company's officers and directors. Resonant raised gross proceeds of approximately $6 million in the Offering.
RESN: 5.32 (-0.18), NHLD: 3.18 (-0.10)
(0)
(0)Scroll down for more posts ▼